Novel harnessing of innate and adaptive anti-cancer immunity: NLRP3-inflammasome activation facilitates immune checkpoint blockade in the treatment of mesenchymal stage IV colorectal cancer - Klimpe, L; Neuwirt, E; Enderle, C; Schäfer, L; Marx, L; Fichtner-Feigl, S; Groß, O; Kesselring, R; Berlin, C (Zeitschrift für Gastroenterologie, 2025)